BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teschke R, Uetrecht J. Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues. Ann Transl Med 2021;9:730. [PMID: 33987428 DOI: 10.21037/atm-2020-ubih-05] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang YL, De Gregorio C, Silva V, Elorza ÁA, Léniz P, Aliaga-Tobar V, Maracaja-Coutinho V, Budini M, Ezquer F, Ezquer M. Administration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifen. Cells 2023;12. [PMID: 36831304 DOI: 10.3390/cells12040636] [Reference Citation Analysis]
2 Teschke R. Treatment of Drug-Induced Liver Injury. Biomedicines 2022;11. [PMID: 36672522 DOI: 10.3390/biomedicines11010015] [Reference Citation Analysis]
3 Teschke R. Aluminum, Arsenic, Beryllium, Cadmium, Chromium, Cobalt, Copper, Iron, Lead, Mercury, Molybdenum, Nickel, Platinum, Thallium, Titanium, Vanadium, and Zinc: Molecular Aspects in Experimental Liver Injury. IJMS 2022;23:12213. [DOI: 10.3390/ijms232012213] [Reference Citation Analysis]
4 Gong JY, Ren H, Chen HQ, Xing K, Xiao CL, Luo JQ. Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS/TLRs/NF-κB Signaling Pathway in Mice. Pharmaceuticals (Basel) 2022;15. [PMID: 36145350 DOI: 10.3390/ph15091130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Fu L, Qian Y, Shang Z, Sun X, Kong X, Gao Y. Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis. Front Med 2022;9. [DOI: 10.3389/fmed.2022.972518] [Reference Citation Analysis]
6 Devaraj E, Uthirappan M. Valproic acid induced liver injury: An insight into molecular toxicological mechanism. Environ Toxicol Pharmacol 2022;:103967. [PMID: 36058508 DOI: 10.1016/j.etap.2022.103967] [Reference Citation Analysis]
7 Woo SM, Alhaqqan DM, Gildea DT, Patel PA, Cundra LB, Lewis JH. Highlights of the drug-induced liver injury literature for 2021. Expert Rev Gastroenterol Hepatol 2022;16:767-85. [PMID: 35839342 DOI: 10.1080/17474124.2022.2101996] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Du Y, Zhang W, Qiu H, Xiao C, Shi J, Reid LM, He Z. Mouse Models of Liver Parenchyma Injuries and Regeneration. Front Cell Dev Biol 2022;10:903740. [DOI: 10.3389/fcell.2022.903740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Teschke R, Vongdala N, Quan NV, Quy TN, Xuan TD. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. Int J Mol Sci 2021;22:10419. [PMID: 34638760 DOI: 10.3390/ijms221910419] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
10 Ramachandran A, Umbaugh DS, Jaeschke H. Mitochondrial Dynamics in Drug-Induced Liver Injury. Livers 2021;1:102-15. [PMID: 34485975 DOI: 10.3390/livers1030010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]